Living with squamous non-small-cell lung cancer

Stories from people navigating squamous non-small-cell lung cancer — diagnosis, treatment, caregiving, and the ordinary days in between.

1 story

Oncology

Ivonescimab Improves Survival in Squamous NSCLC Trial

In China’s phase 3 HARMONi-6 trial, ivonescimab plus chemotherapy improved interim overall survival versus tislelizumab plus chemotherapy in advanced squamous NSCLC.

Rayan Salih · September 2, 2026 · 6 min

Other conditions

ADHD
Allergy
ALS
Alzheimer's Disease
Antimicrobial Resistance
Anxiety
Asthma
Atopic Dermatitis
Atrial Fibrillation
Autism
Breast Cancer
Cervical Cancer

One story a day

The story of the day, in your inbox

One health journey each morning — no advice, no alarm, just company for the road.